Name:
Publisher version
View Source
Access full-text PDFOpen Access
View Source
Check access options
Check access options
Author
Dixon, Meredith GTapia, Milagritos D
Wannemuehler, Kathleen
Luce, Richard
Papania, Mark
Sow, Samba
Levine, Myron M
Pasetti, Marcela F
Date
2022-01-28Journal
VaccinePublisher
ElsevierType
Article
Metadata
Show full item recordAbstract
Measles is endemic in Africa; measles mortality is highest among infants. Infant measles antibody titer at birth is related to maternal immune status. Older mothers are likelier to have had measles infection, which provides higher antibody titers than vaccine-induced immunity. We investigated the relationship between maternal age and measles susceptibility in mother-infant pairs in Mali through six months of infancy. We measured serum measles antibodies in 340 mother-infant pairs by plaque reduction neutralization test (PRNT) and calculated the proportion of mothers with protective titers (>120 mIU/mL) at delivery and the proportion of infants with protective titers at birth, and at three and six months of age. We explored associations between maternal age and measles antibodies in mothers and infants at the timepoints noted. Ten percent of Malian newborns were susceptible to measles; by six months nearly all were. Maternal and infant antibody titers were highly correlated. At delivery, 11% of mothers and 10% of newborns were susceptible to measles. By three and six months, infant susceptibility increased to 72% and 98%, respectively. Infants born to younger mothers were most susceptible at birth and three months. Time to susceptibility was 6.6 weeks in infants born to mothers with measles titer >120-<430 mIU/mL versus 15.4 weeks when mothers had titers ≥430 mIU/mL. Maternal and newborn seroprotective status were positively correlated. Improved strategies are needed to protect susceptible infants from measles infection and death. Increasing measles immunization coverage in vaccine eligible populations, including nonimmune reproductive-aged women and older children should be considered.Rights/Terms
Published by Elsevier Ltd.Keyword
Maternal antibodiesMeasles
Measles immunization
Measles plaque reduction neutralization
Mother-infant
Identifier to cite or link to this item
http://hdl.handle.net/10713/18018ae974a485f413a2113503eed53cd6c53
10.1016/j.vaccine.2022.01.012
Scopus Count
Collections
Related articles
- Maternal HIV infection associated with reduced transplacental transfer of measles antibodies and increased susceptibility to disease.
- Authors: Jallow S, Cutland CL, Masbou AK, Adrian P, Madhi SA
- Issue date: 2017 Sep
- Early loss of passive measles antibody in infants of mothers with vaccine-induced immunity.
- Authors: Maldonado YA, Lawrence EC, DeHovitz R, Hartzell H, Albrecht P
- Issue date: 1995 Sep
- Passive acquired immunity against measles in infants born to naturally infected and vaccinated mothers.
- Authors: Szenborn L, Tischer A, Pejcz J, Rudkowski Z, Wójcik M
- Issue date: 2003 Dec
- Measles vaccine immunogenicity in 6- versus 15-month-old infants born to mothers in the measles vaccine era.
- Authors: Johnson CE, Nalin DR, Chui LW, Whitwell J, Marusyk RG, Kumar ML
- Issue date: 1994 Jun
- Measles Antibodies in Mother-Infant Dyads in Tianjin, China.
- Authors: Boulton ML, Wang X, Wagner AL, Zhang Y, Carlson BF, Gillespie BW, Ding Y
- Issue date: 2017 Nov 27